Literature DB >> 12350188

Rates of spontaneous reporting of adverse drug reactions in France.

Bernard Bégaud, Karin Martin, Françoise Haramburu, Nicholas Moore.   

Abstract

Mesh：

Year:  2002        PMID： 12350188     DOI： 10.1001/jama.288.13.1588

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  42 in total

1.  Safety profile of enantiomers vs. racemic mixtures: it's the same?

Authors:  Céline Caillet; Laurence Chauvelot-Moachon; Jean-Louis Montastruc; Haleh Bagheri
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

2.  Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).

Authors:  Frantz Thiessard; Emmanuel Roux; Ghada Miremont-Salamé; Annie Fourrier-Réglat; Françoise Haramburu; Pascale Tubert-Bitter; Bernard Bégaud
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Contraindication labelling changes in the United States and Germany.

Authors:  Edeltraut Garbe; Frank Andersohn
Journal:  Eur J Clin Pharmacol       Date:  2006-11-24       Impact factor: 2.953

4.  Comparison of hospital episodes with 'drug-induced' disorders and spontaneously reported adverse drug reactions.

Authors:  Paul Barrow; Patrick Waller; Lesley Wise
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

5.  Psychiatric adverse drug reactions to glucocorticoids in children and adolescents: a much higher risk with elevated doses.

Authors:  Neda Tavassoli; Julie Montastruc-Fournier; Jean Louis Montastruc
Journal:  Br J Clin Pharmacol       Date:  2008-05-15       Impact factor: 4.335

6.  Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients.

Authors:  Emmanuelle Guitton; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Eur J Clin Pharmacol       Date:  2006-01-17       Impact factor: 2.953

7.  Risk perception and reasons for noncompliance in pharmacovigilance: a qualitative study conducted in Canada.

Authors:  Vincent Nichols; Isabelle Thériault-Dubé; Julie Touzin; Jean-François Delisle; Denis Lebel; Jean-François Bussières; Benoît Bailey; Johanne Collin
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.

Authors:  Allen D Brinker; Jenna Lyndly; Joseph Tonning; David Moeny; Jonathan G Levine; Mark I Avigan
Journal:  Drug Saf       Date:  2013-12       Impact factor: 5.606

9.  Hemorrhagic effects of oral anticoagulants: a comparative study between vitamin K antagonists (VKA) and direct oral anticoagulants (DOA).

Authors:  J L Montastruc; V Rousseau; L Chebane; D Abadie; E Bondon-Guitton; G Durrieu; F Montastruc; H Bagheri
Journal:  Eur J Clin Pharmacol       Date:  2015-07-22       Impact factor: 2.953

10.  Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project.

Authors:  Paul Avillach; Jean-Charles Dufour; Gayo Diallo; Francesco Salvo; Michel Joubert; Frantz Thiessard; Fleur Mougin; Gianluca Trifirò; Annie Fourrier-Réglat; Antoine Pariente; Marius Fieschi
Journal:  J Am Med Inform Assoc       Date:  2012-11-29       Impact factor: 4.497
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.